GlassScriptPhysician profile
Joel A Williams
NPI 1821072406
$4,652.91
in general payments reported to CMS, 2019-2025
17 companies · $742 in 2025
The $742 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $1,367 · 2021: $896 · 2022: $350 · 2023: $311 · 2024: $525 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,578.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,000.24 | 2019-2020 | |
| Galderma Laboratories, L.P. | $689.36 | 2019-2025 | Dysport |
| Allergan, INC. | $666.44 | 2019-2022 | |
| Abbvie INC. | $588.57 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Mentor Worldwide LLC | $512.90 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Bard Peripheral Vascular, INC. | $347.02 | 2021 | |
| Motiva USA, LLC | $176.36 | 2025 | |
| Merz North America, INC. | $150.33 | 2021 | |
| Rti Surgical, INC | $140.38 | 2024 | |
| Depuy Synthes Sales INC. | $119.57 | 2025 | Na |
| Davol INC. | $96.00 | 2022-2023 | Phasix Mesh |
| Sun Pharmaceutical Industries INC. | $54.98 | 2021-2022 | |
| Tela Bio, INC. | $36.47 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $20.80 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Kci USA, INC. | $20.22 | 2023 | Tegaderm, Prevena Restor Bellaform |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $19.08 | 2019 | |
| Covidien LP | $14.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.